Avoid Phenylpropanolamine and Brompheniramine During Pregnancy
Oral decongestants like phenylpropanolamine should not be used during pregnancy, and first-generation antihistamines like brompheniramine should be avoided due to their sedative and anticholinergic properties. 1
Why These Medications Should Be Avoided
Phenylpropanolamine (Oral Decongestant)
- Increased risk of fetal gastroschisis (abdominal wall defect) 1
- Contributes to maternal hypertension 1
- Has been withdrawn from the US market 1
- While one older study showed symptom improvement, it reported no fetal outcomes and showed no objective improvement on rhinometry 1
Brompheniramine (First-Generation Antihistamine)
- FDA Pregnancy Category C: animal studies not conducted, fetal harm unknown 2
- Should only be given "if clearly needed" per FDA labeling 2
- Contraindicated in nursing mothers due to higher risk of intolerance in infants 2
- Sedative and anticholinergic side effects are problematic 1
- Older literature suggested possible safety concerns compared to other antihistamines 3
Safer First-Line Alternatives
For Nasal Congestion
- Saline nasal rinses/lavage - Safe and effective first-line therapy 1, 4, 5
- Intranasal corticosteroid sprays - Particularly:
For Allergic Symptoms
Second-generation antihistamines (preferred over first-generation):
Intranasal cromoglycate (cromolyn) - First-line option for allergic rhinitis, no teratogenicity reported 8, 5
Clinical Algorithm for Treatment
Step 1: Start with non-pharmacologic measures
- Saline nasal rinses (hypertonic solution preferred) 4
- Nasal valve dilators 5
- Positioning and exercise 5
- Patient education that pregnancy-induced rhinitis resolves postpartum 5
Step 2: If symptoms persist, add intranasal corticosteroid
- Budesonide is the preferred agent 5, 6, 7
- Use at recommended therapeutic doses after proper evaluation 6
Step 3: For allergic symptoms requiring antihistamine
Step 4: For refractory allergic rhinitis
- Consider intranasal cromoglycate 8, 5
- Continue allergen immunotherapy if already initiated pre-pregnancy (do not start or increase doses) 1
Important Caveats
- Avoid all oral decongestants, especially in the first trimester due to cardiac, ear, gut, and limb abnormalities 5, 7
- The evidence prioritizes fetal and maternal safety over simple symptom control 1
- Topical intranasal decongestants have limited safety data and should be used cautiously if at all 8
- Risk-benefit assessment should always favor medications with established safety profiles in pregnancy 6